1. Home
  2. OPK vs MFIC Comparison

OPK vs MFIC Comparison

Compare OPK & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • MFIC
  • Stock Information
  • Founded
  • OPK 2007
  • MFIC 2004
  • Country
  • OPK United States
  • MFIC United States
  • Employees
  • OPK N/A
  • MFIC N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • MFIC Finance/Investors Services
  • Sector
  • OPK Health Care
  • MFIC Finance
  • Exchange
  • OPK Nasdaq
  • MFIC Nasdaq
  • Market Cap
  • OPK 1.0B
  • MFIC 1.2B
  • IPO Year
  • OPK 1995
  • MFIC 2004
  • Fundamental
  • Price
  • OPK $1.39
  • MFIC $12.10
  • Analyst Decision
  • OPK Buy
  • MFIC Buy
  • Analyst Count
  • OPK 4
  • MFIC 6
  • Target Price
  • OPK $2.75
  • MFIC $13.50
  • AVG Volume (30 Days)
  • OPK 2.0M
  • MFIC 391.1K
  • Earning Date
  • OPK 11-06-2025
  • MFIC 11-06-2025
  • Dividend Yield
  • OPK N/A
  • MFIC 12.55%
  • EPS Growth
  • OPK N/A
  • MFIC N/A
  • EPS
  • OPK N/A
  • MFIC 1.08
  • Revenue
  • OPK $664,029,000.00
  • MFIC $324,241,000.00
  • Revenue This Year
  • OPK N/A
  • MFIC $10.46
  • Revenue Next Year
  • OPK $0.84
  • MFIC N/A
  • P/E Ratio
  • OPK N/A
  • MFIC $11.24
  • Revenue Growth
  • OPK N/A
  • MFIC 16.80
  • 52 Week Low
  • OPK $1.11
  • MFIC $10.18
  • 52 Week High
  • OPK $2.04
  • MFIC $14.74
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • MFIC 30.25
  • Support Level
  • OPK $1.34
  • MFIC $12.06
  • Resistance Level
  • OPK $1.44
  • MFIC $12.63
  • Average True Range (ATR)
  • OPK 0.04
  • MFIC 0.21
  • MACD
  • OPK -0.00
  • MFIC -0.11
  • Stochastic Oscillator
  • OPK 50.00
  • MFIC 3.15

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About MFIC MidCap Financial Investment Corporation

MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.

Share on Social Networks: